Clinical Outcomes following Primary Hip Replacement Arthroplasties in Patients with Solid Organ Transplantation: A Systematic Review and Meta-Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
There is still controversy regarding clinical outcomes following primary hip arthroplasty after solid organ transplantation (SOT). The aim of this study was to determine whether clinical outcomes after hip arthroplasty differ between previous SOT recipients and control subjects with no history of undergoing SOT. We conducted a systematic search of MEDLINE, Embase, and the Cochrane Library for studies comparing the clinical outcomes after hip arthroplasty following SOT published up to January 5, 2022. A comparison of medical and surgeryrelated complications, as well as the readmission rate and 90-day mortality rate between previous SOT recipients and control subjects was performed. Subgroup analyses of the SOT types, liver transplantation (LT) and kidney transplantation (KT), were also performed. Ten studies that included 3,631,861 cases of primary hip arthroplasty were included; among these, 14,996 patients had previously undergone SOT and 3,616,865 patients had not. Significantly higher incidences of cardiac complications, pneumonia, and acute kidney injury were observed in the SOT group compared with the control group. Regarding surgical complications, a higher transfusion rate was observed in the SOT group. The readmission rate and 90-day mortality rate were also significantly higher in the SOT group. A significantly higher incidence of deep vein thrombosis was observed in the KT subgroup compared with the control group. A higher risk of medical and surgical complications, as well as higher readmission and mortality rates after hip arthroplasty was observed for previous SOT recipients compared to patients with no history of SOT
Abstract
There is still controversy regarding clinical outcomes following primary hip arthroplasty after solid organ transplantation (SOT). The aim of this study was to determine whether clinical outcomes after hip arthroplasty differ between previous SOT recipients and control subjects with no history of undergoing SOT. We conducted a systematic search of MEDLINE, Embase, and the Cochrane Library for studies comparing the clinical outcomes after hip arthroplasty following SOT published up to January 5, 2022. A comparison of medical and surgeryrelated complications, as well as the readmission rate and 90-day mortality rate between previous SOT recipients and control subjects was performed. Subgroup analyses of the SOT types, liver transplantation (LT) and kidney transplantation (KT), were also performed. Ten studies that included 3,631,861 cases of primary hip arthroplasty were included; among these, 14,996 patients had previously undergone SOT and 3,616,865 patients had not. Significantly higher incidences of cardiac complications, pneumonia, and acute kidney injury were observed in the SOT group compared with the control group. Regarding surgical complications, a higher transfusion rate was observed in the SOT group. The readmission rate and 90-day mortality rate were also significantly higher in the SOT group. A significantly higher incidence of deep vein thrombosis was observed in the KT subgroup compared with the control group. A higher risk of medical and surgical complications, as well as higher readmission and mortality rates after hip arthroplasty was observed for previous SOT recipients compared to patients with no history of SOT
참고문헌 (25)
- Angermeier EW, "Complications of hip and knee joint replacement in solid-organ transplant patients", J Surg Orthop Adv, 22, pp.204~212 (2013)[DOI]
- Kuo FC, "No difference in morbidity and mortality after total joint arthroplasty in liver transplant recipients : a propensity score-matched analysis of a nationwide, population-based study using universal healthcare data", J Arthroplasty, 33, pp.3147~3152 (2018)[DOI]
- Lopez-Ben R, "Incidence of hip osteonecrosis among renal transplantation recipients : a prospective study", Clin Radiol, 59, pp.431~438 (2004)[DOI]
- Cavanaugh PK, "Total joint arthroplasty in transplant recipients : inhospital adverse outcomes", J Arthroplasty, 30, pp.840~845 (2015)[DOI]
- Klement MR, "Complications of total hip arthroplasty following solid organ transplantation", J Orthop Sci, 22, pp.295~299 (2017)[DOI]
- Aminata I, "Perioperative morbidity and mortality of total hip replacement in liver transplant recipients : a 7-year single-center experience", Transplantation, 94, pp.1154~1159 (2012)[DOI]
- Han GJ, "A complication profile of total hip and knee arthroplasty in liver transplantation patients : a metaanalysis", J Arthroplasty, 36, pp.3623~3630 (2021)[DOI]
- Moher D, "Preferred reporting items for systematic review and meta-analysis protocols(PRISMA-P)2015 statement", Syst Rev, 4, pp.1~ (2015)[DOI]
- Shea BJ, "Development of AMSTAR : a measurement tool to assess the methodological quality of systematic reviews", BMC Med Res Methodol, 7, pp.10~ (2007)[DOI]
- Slim K, "Methodological index for non-randomized studies(minors) : development and validation of a new instrument", ANZ J Surg, 73, pp.712~716 (2003)[DOI]
- Schmidt FL, "Fixed-versus random-effects models in meta-analysis : model properties and an empirical comparison of differences in results", Br J Math Stat Psychol, 62(Pt 1), pp.97~128 (2009)[DOI]
- Higgins JPT, "Cochrane handbook for systematic reviews of interventions. Version 5.1.0" (2011), The Cochrane Collaboration
- Agarwal AR, "Increased medical complications following primary total hip arthroplasty in patients with solid organ transplant : a matched cohort analysis", J Arthroplasty, 37, pp.57~61 (2022)[DOI]
- Choi YJ, "Transplantation is a risk factor for acute kidney injury in patients undergoing total hip replacement arthroplasty for avascular necrosis : an observational study", Transplant Proc, 45, pp.2220~2225 (2013)[DOI]
- Douglas SJ, "Primary total hip arthroplasty complications and costs in liver transplant recipients: a matched analysis using a national database", Hip Int (2021)[DOI]
- Ledford CK, "Outcomes of femoral neck fracture treated with hip arthroplasty in solid organ transplant patients", Arthroplast Today, 11, pp.212~216 (2021)[DOI]
- Li X, "Role of total hip replacement arthroplasty between transplantation and acute kidney injury", Ren Fail, 36, pp.899~903 (2014)[DOI]
- Lim BH, "Cementless total hip arthroplasty in renal transplant patients", Hip Int, 22, pp.516~520 (2012)[DOI]
- Malkani JA, "Complications and readmission incidence following total hip arthroplasty in patients who have end-stage renal failure", J Arthroplasty, 35, pp.794~800 (2020)[DOI]
- Navale SM, "The impact of solid organ transplant history on inpatient complications, mortality, length of stay, and cost for primary total hip arthroplasty admissions in the United States", J Arthroplasty, 32, pp.1107~1116 (2017)[DOI]
- Oya A, "Short-term outcomes of total hip arthroplasty after liver transplantation", Arthroplast Today, 8, pp.11~14 (2021)[DOI]
- Blonski W, "Coagulopathy in liver disease", Curr Treat Options Gastroenterol, 10, pp.464~473 (2007)[DOI]
- Chalmers BP, "Survivorship after primary total hip arthroplasty in solid-organ transplant patients", J Arthroplasty, 31, pp.2525~2529 (2016)[DOI]
- Affatato S, "Ceramic-on-metal for total hip replacement : mixing and matching can lead to high wear", Artif Organs, 34, pp.319~323 (2010)[DOI]
- Li Q, "Chronic kidney dysfunction can increase the risk of deep vein thrombosis after total hip and knee arthroplasty", Biomed Res Int, 2017, pp.8260487~ (2017)[DOI]